TNF and inflammatory bowel disease: A retrospective study of people with IBD using the American Veteran Affairs dataset revealed anti-TNF therapies are associated with an increased risk of pneumonia and hospitalization; though this was not stratified by age, 36.5% of persons in this study were >64 years (38).